Water Activity and Cannabis Shelf Life

Understanding Water Activity in Pharmaceutical Cannabis

• Water activity (aw) is a measure of the availability of free water in a product; it is distinct from moisture content and is the critical determinant of microbial growth potential and chemical stability.
• Water activity is measured on a scale of 0 (completely dry) to 1.0 (pure water); pharmaceutical cannabis flower must be dried and cured to an aw of 0.55 to 0.65 to prevent mould while retaining terpene quality.
• Above aw 0.70, Aspergillus and Botrytis species can proliferate rapidly on cannabis flower; below aw 0.50, excessive dryness causes terpene loss, harshness on inhalation and cannabinoid degradation.
• Water activity is measured using calibrated Rotronic, Novasina or METER Group instruments; measurement takes approximately 15 minutes at equilibrium and must be performed on representative samples from each batch.

Water activity is the single most predictive analytical measurement for cannabis shelf life; producers who master aw management during drying and curing consistently deliver superior product quality and longer shelf life.

Drying and Curing to Optimise Water Activity

• Post-harvest cannabis drying in EU-GMP facilities takes place in temperature-controlled drying rooms at 18–22°C and 50–60% relative humidity, typically over 10 to 14 days.
• Slow, controlled drying at moderate temperature preserves terpene content more effectively than rapid drying at elevated temperatures, which drives off volatile aromatic compounds.
• Curing — the post-drying period during which flower is stored in sealed containers — allows water activity to equilibrate throughout the bud structure, producing a more consistent aw measurement.
• Burping curing containers during the first week releases excess moisture and CO₂, preventing anaerobic conditions that can cause fermentation and off-flavours in the finished flower.

The art of post-harvest cannabis management lies in achieving and maintaining the narrow aw window that keeps the product safe, aromatic and pharmacologically intact throughout its shelf life.

Shelf Life Testing and Stability Studies

• EU-GMP cannabis producers conduct formal stability studies under ICH Q1A conditions (25°C/60% RH for long-term, 40°C/75% RH for accelerated) to establish shelf life for each product format.
• Stability indicating tests for cannabis include cannabinoid potency, terpene profiling, water activity, visual appearance, microbial counts and — for extracts — residual solvent content.
• Typical shelf life for properly dried and sealed pharmaceutical cannabis flower is 24 months; oil preparations and capsules may achieve 18 to 36 months depending on formulation and packaging.
• Opened or partially dispensed product has a shortened shelf life; patient dispensing instructions include storage requirements (cool, dark, sealed) and recommended discard dates after opening.

ICH-compliant stability studies provide the regulatory and commercial evidence base for the shelf life claims printed on pharmaceutical cannabis product labels; they are a non-negotiable element of product registration.

Packaging to Maintain Water Activity

• Packaging material selection for pharmaceutical cannabis is governed by moisture vapour transmission rate (MVTR); packaging must maintain aw within specification throughout the stated shelf life.
• Nitrogen-flushed or vacuum-sealed pouches are widely used for cannabis flower to exclude oxygen (which drives cannabinoid degradation) and moisture ingress.
• Silica gel or two-way humidity control packets (e.g. Boveda 62%) are included in some cannabis packaging to buffer aw fluctuations caused by ambient humidity changes during storage.
• Child-resistant, tamper-evident packaging is a regulatory requirement for all UK medical cannabis dispensed to patients; packaging must meet BS EN 14375 or equivalent child-safety standards.

Packaging is the last line of defence in cannabis shelf life management; correctly specified and validated packaging maintains the water activity, cannabinoid potency and microbiological integrity of the product from manufacture to patient use.